Sept 9 (Reuters) - Universal Biosensors Inc UBI.AX :
* APPROVED ON-MARKET BUYBACK OF UP TO 10% OF UBI'S SECURITIES OVER NEXT 12 MONTHS COMMENCING OCT 14
* UBI AND SIEMENS EXECUTED BINDING TERM SHEETS MODIFYING THEIR COMMERCIAL RELATIONSHIP RELATING TO COAGULATION PRODUCTS
* TO PAY SIEMENS US$12.5 MILLION, WITH US$11 MILLION PAYABLE WITHIN 5-DAYS OF EXECUTING INITIAL THREE DEFINITIVE AGREEMENTS
* FORECASTS A NET CASH POSITION OF A$37.1 MILLION AS OF DEC 31, 2019